A University of Alberta clinical trial could offer new hope for people worldwide living with one of the most painful ...
(a) The prescription dose was 12 Gy, delivered to an isodose line of 50.0%. (b) At the six-month follow-up, the tumor shrank significantly. (c) However, a new tumor developed and was treated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results